Advanced Search

Show simple item record

dc.contributor.authorBalaban, Muhsin
dc.contributor.authorÖzkaptan, Orkunt
dc.contributor.authorÇubuk, Alkan
dc.contributor.authorŞahan, Ahmet
dc.contributor.authorDüzenli, Mustafa
dc.contributor.authorTuncer, Murat
dc.date.accessioned2020-03-16T07:56:05Z
dc.date.available2020-03-16T07:56:05Z
dc.date.issued18.01.2020en_US
dc.identifier.issn1342-1751
dc.identifier.issn1437-7799
dc.identifier.urihttps://doi.org/10.1007/s10157-020-01847-2
dc.identifier.urihttps://hdl.handle.net/20.500.12445/1183
dc.description.abstractBackground To evaluate the outcome of endoscopic treatment for symptomatic vesicoureteral refux (VUR) disease in renal transplantation patients and to determine the factors that were associated with the success rate of the treatment. Methods A total of 121 symptomatic VUR diseases diagnosed between 2014 and 2018 in 3560 renal transplant patients. The results of 49 VUR cases that presented with febrile urinary tract infection (UTI) and were hospitalized for antibiotic treatment were included in the study. Refux was detected by voiding cystourethrogram and treatment was performed by endoscopic Defux® injection. The result of endoscopic treatment was evaluated clinically by 3 months periods. Results The mean time between transplantation and endoscopic treatment was 59.6 (5–132) months, and the mean followup period after the endoscopic treatment was 14 (6–48) months, respectively. The success rate after the frst injection was 59.1% (n=29) and 67.3% (n=33) after the second injection. One patient developed anuria, one patient febrile UTI and four patients developed minimal macroscopic hematuria after the procedure. Conclusions Endoscopic treatment of symptomatic VUR in transplanted kidney is a safe and feasible procedure. The amount of bulking agent or duration between the transplantation and diagnosis of VUR does not have any impact on the success of the treatment. However, the younger age of the patients and the female gender seem to have a positive efect on the outcome of the procedure.en_US
dc.language.isoengen_US
dc.publisherSpringer Natureen_US
dc.relation.isversionofhttps://doi.org/10.1007/s10157-020-01847-2en_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectEndoscopic Treatmenten_US
dc.subjectRenal Transplantationen_US
dc.subjectVesicoureteral Refuxen_US
dc.titleEndoscopic treatment of symptomatic VUR disease after the renal transplantation: analysis of 49 casesen_US
dc.typearticleen_US
dc.relation.journalClinical and Experimental Nephrologyen_US
dc.contributor.departmentTıp Fakültesien_US
dc.contributor.authorID0000-0001-9322-9717en_US
dc.identifier.startpage1en_US
dc.identifier.endpage6en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/embargoedAccess
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/embargoedAccess